Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix Gets FDA Emergency Use Authorization for Coronavirus MDx Test

NEW YORK – Rheonix said on Thursday that it has received Emergency Use Authorization from the US Food and Drug Administration for the Rheonix COVID-19 MDx assay.

The endpoint RT-PCR test is processed on the company's Encompass CARD cartridge, which runs on Rheonix's Encompass MDx workstation. It is intended for the qualitative detection of nucleic acid from SARS-CoV-2 in respiratory samples from individuals suspected by their healthcare provider of having COVID-19.

Rheonix said that the assay is fully automated and can provide same-day results for low- and medium-throughput laboratories. The company said that it has begun shipping the workstation and test kits to high-need local and regional hospital laboratories to enable them to begin testing immediately.

Ithaca, NY-based Rheonix is currently seeking full FDA clearance for the Encompass workstation and a triplex sexually transmitted infection assay to simultaneously detect nucleic acid from Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis from patient samples.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.